These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 15946912)

  • 1. Effect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patients.
    Böger CA; Götz AK; Krüger B; Hösl M; Schmitz G; Riegger GA; Krämer BK
    Eur J Med Res; 2005 Apr; 10(4):161-8. PubMed ID: 15946912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives.
    Bozkurt O; Verschuren WM; van Wieren-de Wijer BM; Knol MJ; de Boer A; Grobbee DE; Geerlings MI; Heerdink ER; Klungel OH
    J Hum Hypertens; 2008 Nov; 22(11):774-80. PubMed ID: 18563171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes.
    Bozkurt O; de Boer A; Grobbee DE; Kroon AA; Schiffers P; de Leeuw P; Klungel OH
    J Renin Angiotensin Aldosterone Syst; 2009 Jun; 10(2):101-8. PubMed ID: 19502258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of RAS inhibitors associated with ACE gene polymorphisms in type 2 diabetic nephropathy.
    Seki N; Hashimoto N; Suzuki Y; Yagui K; Saito Y
    Diabetes Res Clin Pract; 2006 May; 72(2):135-41. PubMed ID: 16290123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of gene polymorphisms in the renin-angiotensin system to macroangiopathy in patients with diabetic nephropathy.
    Wong TY; Szeto CC; Chow KM; Chan JC; Li PK
    Am J Kidney Dis; 2001 Jul; 38(1):9-17. PubMed ID: 11431175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
    Robles NR; Romero B; Fernandez-Carbonero E; Sánchez-Casado E; Cubero JJ
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):195-200. PubMed ID: 20026868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albuminuria and the renin-angiotensin system gene polymorphisms in type-2-diabetic and in normoglycemic hypertensive Chinese.
    Thomas GN; Critchley JA; Tomlinson B; Lee ZS; Young RP; Cockran CS; Chan JC
    Clin Nephrol; 2001 Jan; 55(1):7-15. PubMed ID: 11200871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease.
    Buraczynska M; Ksiazek P; Drop A; Zaluska W; Spasiewicz D; Ksiazek A
    Nephrol Dial Transplant; 2006 Apr; 21(4):979-83. PubMed ID: 16384824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of renin-angiotensin system polymorphisms on renal haemodynamic responsiveness to acute angiotensin-converting enzyme inhibition in type 2 diabetes mellitus.
    Volkan-Salanci B; Dagdelen S; Alikasifoglu M; Erbas T; Hayran M; Erbas B
    J Renin Angiotensin Aldosterone Syst; 2009 Mar; 10(1):41-50. PubMed ID: 19286758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure.
    Wu CK; Luo JL; Tsai CT; Huang YT; Cheng CL; Lee JK; Lin LY; Lin JW; Hwang JJ; Chiang FT
    Pharmacogenomics J; 2010 Feb; 10(1):46-53. PubMed ID: 19752885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotypic interactions of renin-angiotensin system genes with diabetes type 2 in a Tunisian population.
    Mehri S; Koubaa N; Hammami S; Mahjoub S; Chaaba R; Nakbi A; Zouari B; Abid M; Ben Arab S; Baudin B; Hammami M
    Life Sci; 2010 Jul; 87(1-2):49-54. PubMed ID: 20580725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin-angiotensin system polymorphisms: a risk factor for progression to end-stage renal disease in vesicoureteral reflux patients.
    Akman B; Tarhan C; Arat Z; Sezer S; Ozdemir FN
    Ren Fail; 2009; 31(3):196-200. PubMed ID: 19288324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The renin--angiotensin system gene polymorphisms and clinicopathological correlations in IgA nephropathy.
    Ong-Ajyooth S; Ong-Ajyooth L; Limmongkon A; Tiensingh A; Parichatikanon P; Nilwarangkur S
    J Med Assoc Thai; 1999 Jul; 82(7):681-9. PubMed ID: 10511770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal function dependent association of AGTR1 polymorphism (A1166C) and electrocardiographic left-ventricular hypertrophy.
    Smilde TD; Zuurman MW; Hillege HL; van Veldhuisen DJ; van Gilst WH; van der Steege G; Voors AA; Kors JA; de Jong PE; Navis G
    Am J Hypertens; 2007 Oct; 20(10):1097-103. PubMed ID: 17903694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of HMG-CoA-reductase inhibitors on survival in type 2 diabetes patients with end stage diabetic nephropathy.
    Götz AK; Böger CA; Hirschmann C; Schmitz G; Riegger GA; Krämer BK
    Eur J Med Res; 2005 Apr; 10(4):155-60. PubMed ID: 15946911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renoprotective efficacy of valsartan in chronic non-diabetic proteinuric nephropathies with renin-angiotensin system gene polymorphisms.
    Lee YJ; Jang HR; Kim SG; Chae DW; Do JY; Lee JE; Huh W; Kim DJ; Oh HY; Kim YG
    Nephrology (Carlton); 2011 Jul; 16(5):502-10. PubMed ID: 21303424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.
    Marre M; Jeunemaitre X; Gallois Y; Rodier M; Chatellier G; Sert C; Dusselier L; Kahal Z; Chaillous L; Halimi S; Muller A; Sackmann H; Bauduceau B; Bled F; Passa P; Alhenc-Gelas F
    J Clin Invest; 1997 Apr; 99(7):1585-95. PubMed ID: 9120002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival in type 2 diabetic patients in dialysis and the number of risk alleles in polymorphisms of the renin-angiotensin system genes.
    Padró-Miquel A; Alía-Ramos P; González-Alvarez MT; Navarro-Moreno MA
    Clin Biochem; 2009 Jan; 42(1-2):5-11. PubMed ID: 19014923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic interactions of renin-angiotensin system genes in myocardial infarction.
    Araújo MA; Goulart LR; Cordeiro ER; Gatti RR; Menezes BS; Lourenço C; Silva HD
    Int J Cardiol; 2005 Aug; 103(1):27-32. PubMed ID: 16061119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.